Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study

Sohier Yahia1, Reham M El-Farahaty, Amany K El-Hawary

  • 1Department of Pediatrics, Faculty of Medicine, Mansoura University Children Hospital, Mansoura, Egypt. amany.hawary.hawary10@gmail.com.

BMC Endocrine Disorders
|October 17, 2012
PubMed

Insights

Obese children with Down syndrome (DS) show elevated fasting glucose and insulin, indicating early insulin resistance. While leptin resistance is similar to simple obesity, myopathy may contribute to obesity in DS.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Genetics

Background:

  • Obesity is more prevalent in individuals with Down syndrome (DS) compared to the general population.
  • The underlying reasons for the increased obesity risk in DS remain unclear.
  • This study investigates obesity-related hormones in prepubertal children with DS.

Purpose of the Study:

  • To clarify differences in obesity-related hormones between children with and without Down syndrome.
  • To assess insulin resistance and leptin resistance in obese children with Down syndrome.
  • To explore potential contributing factors to obesity in Down syndrome.

Main Methods:

  • Compared 36 Egyptian children with DS (23 obese, 13 non-obese) to 43 non-DS children (20 obese, 23 non-obese).
  • Measured fasting blood glucose (FBG), insulin, leptin, free thyroxin (FT4), thyroid stimulating hormone (TSH), and creatine kinase (CK).
  • Assessed insulin resistance using HOMA-IR and leptin resistance using the leptin to BMI ratio (LEP/BMI).

Main Results:

  • Median FBG, insulin, and HOMA-IR were significantly higher in the DS group.
  • Leptin and leptin resistance showed no significant difference between DS and non-DS groups.
  • Four cases of subclinical hypothyroidism were identified in the DS group; leptin correlated with insulin and IR, but not TSH.

Conclusions:

  • Obese children with Down syndrome exhibit similar leptin resistance to those with simple obesity.
  • Elevated FBG and insulin in obese DS children suggest early insulin resistance.
  • Mildly elevated creatine kinase (CK) levels indicate associated myopathy, potentially contributing to obesity in this population.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...